昂利康：拟定增募资11.6亿元 用于创新药研发及产业化项目

Core Viewpoint - The company, Anglikang (002940), announced plans to issue A-shares to specific investors to raise 1.16 billion yuan for innovative drug research and industrialization projects [1] Group 1 - The company aims to raise funds amounting to 1.16 billion yuan through a targeted A-share issuance [1] - The raised funds will be allocated specifically for innovative drug development and industrialization projects [1]